Golden, CO, United States of America

Jason Myers

This inventor holds 16 USPTO granted patents and 2 published patent applications and 5 EPO patents, primarily in Nucleic Acid Preparation. Top assignees: Archerdx, LLC, Life Technologies Corporation, The General Hospital Corporation. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Myers. Retrieved from https://idiyas.com/inventor/jason-myers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 135(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2015)
  • Golden, CO (US) (2017 - 2023)
  • Boulder, CO (US) (2020 - 2023)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Preparation
Sequencing
Bi-Directional Sequencing
Protein Detection
FET Technology
DNA Analysis
Cell-Free DNA
Immune Repertoire
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jason Myers: A Pioneer in Nucleic Acid Technology

Introduction

Jason Myers is a distinguished inventor hailing from Golden, Colorado. With a remarkable portfolio of 14 patents to his name, he has made significant contributions to the field of nucleic acid technology. His innovations have paved the way for advancements in sequencing methods crucial for research and medicine.

Latest Patents

Among his latest innovations are patents related to the preparation of nucleic acids for sequencing. The patents encompass methods that enhance the preparation and analysis of nucleic acids, providing improvements in sequence analysis, particularly through next-generation sequencing techniques. These advancements highlight his commitment to enhancing scientific methodologies and accessibility.

Career Highlights

Throughout his career, Jason has collaborated with prominent companies such as Life Technologies Corporation and ArcherDx, LLC. His experience in these organizations enabled him to refine his expertise and contribute to groundbreaking research in nucleic acid technologies. His work has not only been pivotal for the companies he served but also influential in the broader scientific community.

Collaborations

Jason has had the privilege of collaborating with talented professionals like Joshua Stahl and Zhoutao Chen. These partnerships have fostered a conducive environment for innovation, allowing for the exchange of ideas and the evolution of groundbreaking technologies in nucleic acid preparation and analysis.

Conclusion

In conclusion, Jason Myers stands out as a key figure in the field of nucleic acid technology. With his impressive array of patents and collaborations, he continues to impact the scientific landscape significantly. His passion for innovation not only benefits his immediate projects but also contributes to the overall advancement of genetic research and its applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…